mini-hyper-cvd ino followed by blina consolidation for r/r all
Published 1 year ago • 136 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
1:03
updated results of hyper-cvad and blinatumomab /- inotuzumab ozogamicin in newly-diagnosed b-all
-
2:50
insights into the ca057-003 trial: mezigdomide, tazemetostat & dexamethasone for r/r myeloma
-
1:36
the use of outpatient cilta-cel in the treatment of multiple myeloma
-
2:14
a new classification for identifying high-risk myeloma based on cytogenetic abnormalities
-
3:54
a case study from the ecog-e1910 trial: early blinatumomab treatment in all
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:32
ivim technology - the new all-in-one ivim series v.3
-
23:45
venous thromboembolism (dvt, pe) | clinical medicine
-
16:26
adamonitor mm6 video of use (english)
-
1:13
using integrative multiomics to explain myeloma progression and evolution of refractory disease
-
1:18
identifying high-risk myeloma: looking beyond cytogenetic factors
-
1:16
mechanisms of resistance to the tki asciminib in cml
-
1:32
the use of belantamab mafodotin in triplet combinations for multiple myeloma
-
7:14
hvivo omicron human challenge model
-
0:52
using spatial proteomics to analyze the bone marrow microenvironment in smm treated with nivolumab
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
1:13
the allg cml13 ascend-cml study: high major molecular responses with asciminib treatment for cp-cml
-
3:14
108-nemox_gelato_10k _guide_2401
-
1:07
propel mini prep video
-
2:47
the innovators behind the enlite sensor
-
3:43
envision™ pro sensor insertion video
-
1:49
genomic advancements in non-malignant hematology